You're Not Losing Muscle Because You Got Lazy

You're doing everything right. You still train. You still show up. The weights haven't gotten lighter and your effort hasn't dropped. But somewhere in the last few years, the math stopped working. You put in the same work and get back half the result. Recovery takes longer. The mirror tells a different story than it used to, even though your habits haven't changed.

So you do the thing everyone does. You blame yourself. You decide you've gotten soft, or lazy, or that this is just what getting older feels like. And maybe you went to your doctor, who ran a panel, glanced at it, and told you everything looks normal. You left more confused than when you walked in.

Here's the truth that reframes everything: you're not losing muscle because you got lazy. You're losing it because the signal that builds muscle got quieter, and no amount of effort fully replaces a signal that isn't firing.

What's Actually Happening Inside the Muscle

Muscle isn't built by lifting alone. Lifting creates the demand. What answers that demand is a cascade of biological signals, and testosterone sits near the top of that chain. When testosterone binds to a structure on your muscle cells called the androgen receptor, it switches on a master growth pathway known as mTOR.

Think of mTOR as the muscle's construction foreman. When it's active, it drives protein synthesis, the process that turns the raw material from your diet into new muscle fiber. It also activates satellite cells, the repair crew that rebuilds and reinforces muscle after you train. When the signal is strong, the foreman shows up and the crew gets to work. When the signal weakens, the demand from your training is still there, but fewer workers answer the call.

This is the part conventional advice misses. The research on this is mechanistically clear: testosterone signals through both the androgen receptor and mTOR to produce muscle growth, and when you block either pathway, the growth response falls apart. Effort sets the demand. Hormones determine how much of that demand actually gets met.

The Slow Fade Nobody Warns You About

After about age 35, testosterone in men declines at roughly one to two percent per year. That number sounds small, and at first it is. You don't wake up one morning feeling different. The decline is slow enough that you adapt to it without noticing.

But compound one to two percent over a decade and the gap becomes real. The same workout that built muscle at 35 now barely maintains it at 47. Body composition shifts even when the scale holds steady. Fat creeps in where muscle used to be. And the most frustrating part is that none of this shows up as a dramatic crash. It's a gradual erosion, which is exactly why people blame their own discipline instead of their biology.

The decline is real, measurable, and gradual. That's precisely why it gets mistaken for a personal failing instead of a physiological one.

Why "Normal" Labs Miss the Real Problem

This is where most testosterone testing falls short. When a standard panel checks your testosterone, it usually measures total testosterone, which is everything circulating in your blood. The problem is that most of that testosterone isn't actually available to your muscle cells. It's locked up, bound to a protein called sex hormone-binding globulin, or SHBG.

Only the unbound fraction, called free testosterone, can reach the androgen receptor and switch on the growth signal. And here's the catch that ties the whole story together: SHBG rises as you age. So even if your total testosterone looks respectable on paper, a growing share of it is bound and inactive. The number on your lab report can look fine while the number that actually matters quietly falls.

Two men can walk in with an identical total testosterone of 500. One has low SHBG and plenty of free, available testosterone. The other has high SHBG, and functionally his muscles are working with the testosterone of a man at half that number. Same lab value. Completely different biology. If your panel only measured total testosterone, you'd never know which man you are.

This is the difference between a result that's technically normal and a result that's actually optimal for how you feel and function. The reference range tells you that you fall within the broad population spread. It doesn't tell you whether your biology is doing what you need it to do.

What the Evidence Shows

The relationship between available testosterone and muscle isn't a clinical hunch. In a controlled dose-response trial, researchers gave healthy men carefully graded doses of testosterone and measured the result. Muscle mass and strength increased in direct proportion to the dose. More available testosterone meant more muscle, in a clean, dose-dependent line. This is direct evidence that the amount of testosterone reaching your tissue isn't a minor detail. It's a primary lever on how much muscle you can hold.

Pair that with the mechanistic work showing testosterone driving muscle growth through the androgen receptor and mTOR, and the picture is complete. The signal builds the muscle. The strength of the signal determines the outcome. When the signal fades with age and gets further muted by rising SHBG, the result you see in the mirror is not a character flaw. It's biology following its own rules.

A Patient You Might Recognize

Consider a composite picture drawn from patterns I see often. A patient in their early fifties comes in frustrated. They've trained consistently for years. Over the last two or three years, despite no change in effort, they've watched strength plateau and slowly slip, while a layer of fat settled in that wasn't there before. Their previous doctor ran a testosterone panel, saw a total number inside the reference range, and sent them on their way with a shrug.

When we look closer, the total testosterone is indeed mid-range. But the free testosterone is low, and SHBG is elevated. The available signal is far weaker than the headline number suggested. Nothing about this person's discipline was the problem. The standard panel simply never measured the thing that mattered.

What This Means for You

If you've been blaming yourself for a body that stopped responding, it's worth stepping back and asking whether the real issue was ever effort at all. The honest path forward starts with measuring the right things. That means looking beyond total testosterone to free testosterone, SHBG, and the broader hormonal picture, so you understand what your muscle cells are actually working with.

It's worth being clear-eyed here. Hormone optimization isn't a shortcut, and it isn't for everyone. It requires proper evaluation, ongoing monitoring, and an honest conversation about benefits, individual variability, and what the data does and doesn't support. The point isn't to chase a number. The point is to restore a signal that's been quietly fading, so the work you're already putting in finally produces the result it should.

You were never lazy. The signal got quiet. The work starts with finding out by exactly how much.

Let's Talk

If this sounds like your experience, you don't have to keep guessing. A free consultation is a straightforward conversation about your symptoms, your goals, and whether a deeper look at your hormones makes sense for you. It's bookable virtually, on your schedule. No pressure, no commitment, just a chance to finally get answers that the standard panel never gave you.

This content is for educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Hormone therapy involves potential risks and benefits that vary by individual and requires evaluation and ongoing monitoring by a qualified physician. Some therapies discussed may involve off-label use. Always consult a licensed healthcare provider before making decisions about your health.

References

1. Basualto-Alarcón C, Jorquera G, Altamirano F, Jaimovich E, Estrada M. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Med Sci Sports Exerc. 2013;45(9):1712-1720. PMID: 23470307

2. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172-E1181. PMID: 11701431

Progesterone Is Being Prescribed to Men. Here's Why That's a Problem.

Some men on hormone therapy aren't getting better. Their energy is flat. Their libido is low. Their labs look reasonable on paper. But they don't feel optimized — and when you look at their protocol, one thing stands out.

Progesterone.

It's in more male protocols than it should be. Some providers include it for "balance." Some offer it as a sleep aid. The intentions may be reasonable. The biology is not.

Progesterone is a powerful hormone. In female physiology, it's essential — stabilizing, protective, deeply beneficial. But the female body evolved to receive it. The male body did not. And the research on what progesterone actually does inside a man makes that distinction impossible to ignore.

Problem 1: Progesterone Drives Inflammation in Men

Start with the data.

A 2005 study published in the Journal of Clinical Endocrinology & Metabolism examined the relationship between progesterone and inflammation in healthy men — not sick men, not men on medications. Healthy men, aged 20 to 50.

In the first arm, researchers measured endogenous progesterone levels and compared them against a panel of inflammation markers. The findings were unambiguous. Higher progesterone tracked directly with elevated IL-6, C-reactive protein, VCAM-1, E-selectin, and neutrophil counts. Every marker moved in the wrong direction as progesterone rose.

The second arm was a controlled trial. Men who received an exogenous progestin alongside testosterone saw IL-6 spike sharply. Anti-inflammatory IL-10 — the body's counter-regulatory response — dropped significantly. Men receiving testosterone alone showed the opposite: their inflammatory profile improved.

The authors concluded directly: progesterone corresponds to an inflammatory profile in healthy men, and exogenous progestins amplify that effect.

This is not a theoretical concern. IL-6 and CRP are not obscure research endpoints. They are markers of systemic inflammation — the same inflammatory burden that drives cardiovascular disease, metabolic dysfunction, insulin resistance, and accelerated biological aging. A protocol increasing that burden isn't optimizing anything. It is working against the very outcomes it claims to support.

Problem 2: Progestins Tell the Male Hormonal Axis to Shut Down

The second problem runs deeper.

Progestins suppress LH and FSH — the gonadotropins that drive endogenous testosterone production. This isn't a side effect. It's a primary pharmacological mechanism. It's exactly why progestins have been studied for decades in male hormonal contraception research: combined with testosterone, they drive pituitary output toward zero and shut down spermatogenesis. This has been demonstrated in clinical trials, published in peer-reviewed literature, and replicated across multiple progestin compounds.

What this means in the context of hormone optimization: adding a progestogen to a male protocol means adding a compound that pharmacologically signals the hypothalamic-pituitary axis to stand down. Less LH. Less FSH. Less endogenous testosterone stimulus.

A man on exogenous testosterone may not feel this acutely — his levels are being replaced. But the axis-level interference doesn't disappear. You are running an optimization protocol with one hand while using the other to suppress the system that protocol depends on.

There is no legitimate optimization rationale for this in men.

Problem 3: This Is the Same Compound Class Used to Eliminate Male Sexual Function

Here is what makes the clinical picture impossible to rationalize.

Progestogens — specifically medroxyprogesterone acetate — are used clinically in the management of male sex offenders. The therapeutic goal is the deliberate suppression of male sexual function. The published literature documents the effects with precision: reduced libido, diminished erectile capacity, decreased sexual arousal, blunted drive.

That is not a side effect. That is the intended mechanism. It is the reason it works for that purpose.

Now consider the population walking into hormone optimization clinics. Men presenting with low libido. Men with erectile dysfunction. Men who feel flat, disengaged, sexually underperforming. These are the exact symptoms that bring people through the door.

And some of those men are being given a compound class whose documented mechanism in male physiology is the suppression of exactly those functions.

That's not an overstatement. It is a direct reading of the published clinical literature. The compound being offered as part of the solution shares a mechanism with drugs used deliberately to eliminate male sexual function.

Why the Confusion Persists

Progesterone has a genuinely impressive clinical profile — in women.

Better sleep. Cardiovascular protection. Mood stability. Endometrial balance. The evidence base in female BHRT is strong. The benefits are real.

The error is transferring that profile across a physiological boundary where it doesn't apply. Steroid hormones don't work the same way in every body. The response depends entirely on the cellular environment receiving the signal: which receptors are expressed, how they're wired, what downstream pathways activate.

Men and women do not run the same hormonal operating system. Progesterone belongs in female physiology. The data on what it does in male physiology — inflammation, gonadotropin suppression, sexual dysfunction — is not ambiguous.

What I See in Practice

When a man comes in not responding to what should be a well-constructed protocol, progesterone is one of the first things I look at.

The presentation is often subtle. Energy that should be better by now. Sleep that hasn't improved the way it should. Libido that isn't where it needs to be. Inflammatory markers on labs that don't have a clean explanation.

Consider a patient in his mid-50s: active, otherwise healthy, two years into testosterone therapy. Testosterone levels optimized. Thyroid addressed. CRP still elevated. Energy inconsistent. His prior protocol included progesterone — added by a previous provider for sleep support.

Removing the progesterone and restructuring the protocol around compounds appropriate for male physiology: CRP normalized. Sleep improved. Energy stabilized. Nothing dramatic was added. Something that didn't belong was removed.

That is frequently how optimization actually works. It isn't always about adding more. It's about identifying what's creating friction and eliminating it.

What Belongs in a Male Hormone Protocol

A well-constructed male protocol is built around what the male endocrine system is designed to use.

Testosterone optimization — not just reaching a reference range, but achieving the balance of free testosterone, total testosterone, estradiol, and SHBG that produces genuine clinical results.

Thyroid — not just TSH, but Free T3, Free T4, and the conversion pathway where the clinically meaningful information actually lives.

DHEA-S and pregnenolone — compounds the male adrenal and neurological systems are equipped to use effectively, frequently low in men presenting with fatigue and cognitive decline.

Progesterone is not on that list. Not because it was overlooked. Because the male endocrine system wasn't built to use it — and three separate lines of clinical evidence explain what happens when it tries.

The same compound class used clinically to suppress male sexual function is appearing in male hormone optimization protocols. That gap between what the data shows and what some providers prescribe is exactly where patient outcomes get lost.

Is Your Protocol Actually Built for You?

If you're on a hormone protocol that includes progesterone and you haven't felt optimized, that's worth examining — not as a coincidence, but as a mechanism.

A thorough evaluation looks at the full panel: free testosterone, SHBG, estradiol, thyroid function, DHEA-S, cortisol, and inflammatory markers. From there, the goal is a protocol built around what your physiology is designed to use.

Virtual consultations are available and the first conversation is free. Bring your labs if you have them. The goal is a straight answer about whether your protocol is actually working for you — or against you.

References

1. Zitzmann M, Erren M, Kamischke A, Simoni M, Nieschlag E. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab. 2005 Dec;90(12):6603–8. — PMID: 16204370

2. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab. 1996 Nov;81(11):4113–21. — PMID: 8923869

3. Cooper AJ. Progestogens in the treatment of male sex offenders: a review. Can J Psychiatry. 1986 Feb;31(1):73–9. — PMID: 2936441

[DISCLAIMER]

This content is for educational purposes only and does not constitute medical advice. Hormone therapy involves individualized clinical evaluation and is not appropriate for everyone. Always consult a qualified healthcare provider before starting, stopping, or modifying any hormone protocol.